01:58 PM EDT, 05/04/2026 (MT Newswires) -- Health care stocks declined Monday afternoon, with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each decreasing 0.3%.

The iShares Biotechnology ETF (IBB) rose 1.3%.

In corporate news, Amgen ( AMGN ) said Monday it will invest an additional $300 million in its biologics manufacturing facility in Puerto Rico. Amgen ( AMGN ) shares were down 2.1%.

Vanda Pharmaceuticals ( VNDA ) shares jumped past 5% after it said Monday its motion sickness drug Nereus is now commercially available in the US.

Eli Lilly ( LLY ) shares added 0.2% after Barclays lifted the company's price target to $1,400 from $1,350, while keeping its overweight rating.

Moderna ( MRNA ) is showing continued advancement across its pipeline, with progress in cancer vaccines and infectious disease programs supporting a more balanced risk-reward profile, RBC Capital Markets said in a note. RBC maintained its sector perform rating on the stock and raised its price target to $38 from $35. Moderna ( MRNA ) shares rose 4.6%.